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Abstract
Background: This study examined how mental health clinic administrators decided whether or not to adopt
evidence-based and other innovative practices by exploring their views of implementation barriers and facilitators
and operation of these views in assessment of implementation costs and benefits.
Methods: Semi-structured interviews were conducted with 75 agency chief executive officers and program
directors of 34 New York State-licensed mental health clinics serving children and adolescents.
Results: Three interconnected themes relating to barriers and facilitators were identified, namely costs and benefits
associated with adoption, capacity for adoption, and acceptability of new practices. The highest percentage of
participants (86.7%) mentioned costs as a barrier, followed by limited capacity (55.9%) and lack of acceptability
(52.9%). The highest percentage (82.3%) of participants identified available capacity as a facilitator, followed by
acceptability (41.2%) and benefits or limited costs (24.0%). Assessment of costs and benefits exhibited several
principles of behavioural economics, including loss aversion, temporal discounting use of heuristics, sensitivity to
monetary incentives, decision fatigue, framing, and environmental influences.
Conclusions: The results point to opportunities for using agency leader models to develop strategies to facilitate
implementation of evidence-based and innovative practices for children and adolescents.
Keywords: Innovation, Adoption, Evidence-based treatments and practices, Mixed methods, Child and adolescent
mental health
Background
Despite substantial evidence of their effectiveness,
evidence-based practices (EBPs) in mental health services
for children and adolescents continue to be underutilised
[1, 2]. In the past decade, much research has been devoted
to understanding the reasons for the underutilisation of
EBPs in all forms of mental health services and how this
situation can best be remedied so that clients can receive
the highest quality of care [3–5]. This research has led to
a proliferation of EBP implementation models that identify
characteristics of the EBP itself, the organisations and in-
dividuals tasked with implementing the intervention, and
the external environment in which such implementation
occurs, which may either serve as implementation barriers
or facilitators [6–8]. The development of strategies to
facilitate EBP implementation has relied upon this work
to identify the barriers that must be overcome and the
facilitators that can assist in this task.
Although there seems to be general consensus as to
the potential of such theories, models and frameworks
for facilitating implementation of EBPs and other in-
novative practices, some [9, 10] have questioned their
value for understanding and guiding implementation
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and pointed to their limitations for connecting implemen-
tation theory with practice. For instance, frameworks and
models in general provide checklists of potential determi-
nants of successful implementation but do not prioritise
them or indicate which are most important or predictive
of implementation outcomes and which are the least [11].
Further, as Proctor et al. ([12], p. 72) observe, “the
success of efforts to implement evidence-based treatment
may rest on their congruence with the preferences and
priorities of those who shape, deliver, and participate in
care. Implementation outcomes may be differentially
salient to various stakeholders, just as the salience of
clinical outcomes varies across stakeholders”. A study
by Seffrin et al. [13] found that the proportion of facili-
tators to the sum of facilitator and barrier comments
made by project informants were higher for innovative
mental health projects that proceeded with implemen-
tation than those that did not.
Related to the lack of information on stakeholder pref-
erences and priorities for implementation is a limited
understanding of the principles and processes of decid-
ing whether or not to adopt, implement and sustain a
new and innovative practice. Panzano and Roth [14]
found that the propensity to adopt an innovative mental
health practice was negatively related to the perceived
risk of adopting the practice and positively related to
expected capacity to manage risk and an organisation’s
past propensity to take risks. Whether leaders of mental
health service agencies consider factors in addition to
risk aversion when making decisions on whether or
not to adopt an innovative program or practice is not
entirely clear.
To better understand the key factors involved in decid-
ing whether or not to adopt an EBP or other innovative
practice, we conducted a qualitative study to construct an
agency leadership model of implementation by exploring
the following: (1) the most salient or important barriers
and facilitators to innovation and adoption of EBPs for
children and adolescents as determined by executive
directors and program directors of mental health clinics in
New York State; and (2) how these barriers and facilitators




The present study included 75 agency CEOs, vice presi-
dents and program directors representing a 10% random
stratified sample of 346 clinics (n = 34) licensed by the
New York State Office of Mental Health (OMH) to treat
youths in New York State. These 34 clinics were randomly
selected based on their level of adoption of EBPs in New
York State, as operationalised in Chor et al. [15]. After
completing informed consent procedures for participating
in research, each participant completed a semi-structured
interview conducted between August 2013 and June 2014.
The number of interviewees per clinic ranged from one
to three. The study was reviewed and approved by the
Institutional Review Boards at New York University
and the University of Southern California.
Data collection
All interviews were conducted using a semi-structured
interview guide consisting of a series of questions that
focused on understanding (1) why OMH-licensed, out-
patient, child-serving agencies and clinics adopt inno-
vations in the context of healthcare reform; and (2)
multi-level (system-, agency-/clinic-, staff-, client- and
innovation-levels) processes and factors in adoption,
non-adoption and de-adoption of innovations. Partici-
pants were informed at the outset that innovations can
be EBPs for specific psychiatric disorders; they can also
be quality improvement initiatives, which are activities
that improve the structures, processes and outcomes of
care of a clinic. Questions were drawn from previous stud-
ies of EBP dissemination and implementation [16, 17] and
were designed to obtain information on knowledge of
innovations (e.g. How does your agency generally first
hear about an innovation?), innovations adopted (e.g.
What types of innovations has your agency adopted?),
adoption decision-making (e.g. What motivates or drives
your agency to adopt an innovation?), and facilitators and
barriers of adoption of innovations. In this last category of
questions, participants were asked the following: (1) What
are the major factors (facilitators) that make it possible to
adopt these innovations? (2) What are the major factors
(barriers) that make it difficult to adopt these innovations?
and (3) What are the top three barriers? All interviews
lasted approximately 1 hour and were digitally recorded.
Data analysis
A thematic content analysis methodology of “Coding
Consensus, Co-occurrence, and Comparison” [18] was
used to analyse the semi-structured interviews. Audio-
recorded interviews were transcribed and reviewed by
four investigators, who developed lists of codes individu-
ally. These codes were subsequently discussed, matched
and then integrated into a single codebook. The final list
of codes, constructed through a consensus of team mem-
bers, consisted of responses to specific questions related
to perceived barriers and facilitators to adoption of
innovative practices. Inter-rater reliability in the assign-
ment of specific codes to specific transcript segments was
assessed for a subset of randomly selected pages from
10 randomly selected transcripts. For all coded text
statements, the coders agreed on the codes 91% (range,
88–94%) of the time, indicating good reliability in
qualitative research [19]. A web-based qualitative data
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management program, Dedoose [20], was used for cod-
ing and generating a series of categories arranged in a
treelike structure connecting text segments as separate
categories of codes or ‘nodes’. Through repeated com-
parisons of these categories with one another, these
nodes and trees were used to create a taxonomy of
themes that included both a priori and emergent cat-
egories and new, previously unrecognised categories.
These nodes and trees were used to further the process
of axial and pattern coding [21].
As every interview participant was asked to identify
the three top barriers and facilitators, we quantified the
number of responses to these answers by category or
theme and subcategory to determine what barriers and
facilitators were most often mentioned as an indicator of
their significance or salience.
Results
A list of barriers and facilitators to adopting innovative
and EBPs and the percentage of study participants who
mentioned a specific barrier or facilitator is presented in
Table 1 below. The highest percentage of participants
(86.7%) mentioned costs as a barrier, followed by limited
capacity (55.9%) and lack of acceptability (52.9%). With
respect to facilitators, the highest percentage (82.3%) of
participants identified available capacity, followed by ac-
ceptability (41.2%) and benefits or limited costs (24.0%).
Costs and benefits of adoption
Analysis of the qualitative data revealed three central
themes of barriers and facilitators to implementing
EBPs. The first theme focused on issues of cost and in-
cluded additional time required to train staff, direct
costs, reduced productivity, staff turnover, resource re-
quirements for use of the EBP, and lack of evidence of
the innovation’s benefits. Parallel to the theme of costs
as a barrier were benefits and reduced costs as a facilita-
tor. This theme included available time, evidence of
positive outcomes associated with the innovation, flexi-
bility in use of the innovation, little impact on the organ-
isation and availability of the innovation for free or at
low cost.
The cost of implementing a new program or practice
was the most frequently cited barrier. One agency chief
executive officer explained, “…the first thing I look at is
how much is this gonna cost us if we try to implement it.
Because I mean, right now finances are a mess through
most of the system for agencies that are working with
kids, especially the size of [our agency], that’s a small to
medium agency”.
The most frequently cited cost was associated with the
training of staff. Such training involves two types of
costs, the cost of the training itself and the lost revenues
that occur when staff members are not seeing clients
while they are getting trained. Training costs include the
expense of paying for someone skilled in the practice to
train one’s staff, purchasing of treatment manuals or
other instructional aids, and perhaps travel expenses of
staff who are sent elsewhere for training. Most import-
antly, training results in lost productivity and revenue
“because as soon as you’re sending someone to a training,
they’re not doing billable services” (Program director).
This, in turn, results in reduced productivity of the
agency as a whole. On the other hand, the availability of
training for free or low cost was cited as a facilitator to
adoption: “Yeah, so certainly any organised external ef-
fort or webinar or the ability to send people to a training
on an evidence based practice that is comprehensive and
Table 1 Percentage of study participants identifying specific
adoption barriers and facilitators
Barriers Percent Facilitators Percent
Costs 86.7 Benefits or limited costs 24.0
Time for training 54.4 Available time 19.4
Training expenses 47.1 Evidence of positive
outcomes
14.9
Impact on organisation 23.5 EBP flexibility 7.4
No evidence of
outcomes
8.8 Little impact on
organisation
6.0
Staff turnover 5.9 Free/low costs 6.0
EBP requirements 4.4
Barriers Facilitators
Capacity 55.9 Available capacity 82.3
Lack of trained staff 19.1 Training access 44.7





13.2 Available trained staff 38.8
Financial reimbursement 8.8 Support from leadership 16.4
Training access 7.4 Organisational resources 14.7




Presence of a champion 4.5
More information 3.0
Interagency network 1.5
Acceptability 52.9 Acceptability 41.2
Staff fit and buy-in 32.4 Staff motivation to
change
14.9
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free, is one that we…that certainly makes it easier for us
to participate in” (Agency CEO).
In addition to lost revenues and productivity, partici-
pants cited other costs associated with the impact of
adoption on the organisation as a whole. A number of
participants cited the additional paperwork associated
with the adoption of a new practice. Others cited the
additional workload that would affect staff morale be-
cause it would make it more difficult “to be able to stay
current, to read, to take a deep breath, to look at
things…” (Agency CEO).
Lack of evidence of positive outcomes is another bar-
rier because it calls into question the benefits of adopt-
ing the innovation. As one agency CEO observed, “I’m
not going to take a bunch of clients who are doing fairly
well and switch them over to some other treatment mode,
unless I have a fairly good sense that they’re going to do
as well, or if not a little bit better. And I don’t always get
that all right”.
Another cost associated with training is potential staff
turnover. As explained by one program director: “You’re
investing in a staff member for, let’s say a year in a train-
ing program and then they think that experience is great,
and they go to another place… People don’t see how
much it costs to the agency, unfortunately”.
Related to the cost of training staff are the costs in-
volved in supervising staff to use the practice with fidelity:
“Because now if you have any new model, somebody has to
oversee it and supervise it. And that again, becomes a
money and time factor of who’s going to have the time to
now supervise this model and make sure it’s being done
effectively” (Program director). Practicing with fidelity also
may require additional time, which can reduce productiv-
ity: “So for example, the CPT requires forty-five minutes.
That means that for the clinicians that are implementing
this model, we don’t have that flexibility of scheduling their
patients in those thirty-minute slots to increase productiv-
ity” (Agency vice president). In contrast, flexibility in
adapting the innovation to the practice was considered a
facilitator to adoption.
Capacity for adoption
The second theme focused on issues of clinic capacity to im-
plement the EBPs. Barriers included lack of trained staff,
lack of organisational capacity and resources, environmental
constraints, lack of financial reimbursement for implement-
ing the innovation, limited access to training, lack of tech-
nical support, and lack of support from leadership.
Facilitators related to capacity for adoption included avail-
able training, funding or financial support and incentives,
trained staff, leadership that was supportive of the adoption,
organisational resources, a regulatory mandate, supervision,
the presence of an innovation champion, more information
about the innovation, and access to an interagency network.
While the additional costs associated with training and
supervising staff and an increased workload and time
devoted to using the innovation with fidelity may be
viewed as a disincentive to adoption, there is the add-
itional risk of not being adequately reimbursed for incur-
ring these costs. One of the program directors cited a
specific practice, dialectical behaviour therapy, as an
illustration: “I think it’s very hard to implement in an
outpatient mental health clinic. Maybe it won’t be, once
we have those capitated rate, but the way that things are
now where you do a fee per session model doesn’t really
work with DBT [dialectical behaviour therapy]”. An
agency vice president also noted: “you can’t bill for the
type of supervision that’s required to remain with the
fidelity of the model”. Consequently, “one of the major
barriers to provision of services to children, is they are
highly labor intensive and not reimbursed at such
wonderful levels as it’s easy to afford them”.
Even if one were to obtain reimbursement for training
and supervision, the limited access to useful resources is
also an important barrier to adoption. Participants noted
the paucity of high quality training opportunities and
the absence of supervision as a follow-up to training as
barriers to adopting innovations. According to one
agency CEO, “We’ve been trained in a number of these
practices. But there is not a depth in New York State to
provide fidelity based supervision”.
Lack of trained staff is another important barrier. This
includes the lack of staff qualified to use the innovation,
the lack of staff available to be trained, and the lack of
support staff. As one program director noted: “Yes. I
think the number one [barrier] is just not having enough
staff. And that’s really the main thing because not
enough staff everybody takes on more tasks. You know, it
seems like we’re always asking people to do more. The
staff here haven’t had raises in four years”.
Another barrier to adoption relates to constraints on
capacity imposed on an agency by its external environ-
ment. Often mentioned by participants was the challenge
of providing mental health services to school-age clients
during school hours. Another environmental constraint is
the absence of a regulatory policy governing implementa-
tion. This constraint is also associated with the limited cap-
acity to obtain reimbursement for using the innovation.
For instance, one agency vice president noted a challenge
with the transition to Medicaid managed care: “We’ve had
problems with managed care companies approving evi-
dence based models for group therapy because they don’t
want to pay for it, which then you’ve got to fight them,
appeal it, you know that kind of stuff. So I think it’s a lot of
those things that really are the barriers”.
However, regulations that mandate services may also
be seen as a facilitator in that they eliminate the need to
make a decision: “Yeah, the most obvious is if there’s a
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regulatory change I have no choice. I mean, I get to go to
my boss and say, we have no choice we have to do this in
order to be compliant” (Agency CEO).
Related to the lack of fit is a lack of support from the
agency’s leadership. As noted by one program director,
“barriers are definitely if the executive team doesn’t agree
with what we’re trying to do or doesn’t feel that it is the ap-
propriate initiative to expend a lot of time and energy on”.
The presence of a champion for the innovative pro-
gram or practice within the agency was cited as a facili-
tator that enhanced an agency’s capacity to adopt an
innovation. While innovation champions could be senior
administrators or supervisors, they may also be frontline
staff. In either case, “you’ve got to have some people who
are excited about it, who take it on and who believe, and
who are able to communicate enthusiasm to the other
staff and help support them through the implementa-
tion… If you don’t have that then you can’t change the
culture” (Program director).
Another facilitator related to capacity is the ability to
provide financial incentives to staff. As explained by an
agency director, “So… a clinician reaches one hundred
percent productivity, they are full time staff in the union,
salary, benefits, they reach a hundred percent and then
they go over a hundred percent. They’re fabulous; they
have a great week. We would like to incentivize that and
say for every session you go over we can either reimburse
you at a fee for service rate, we can give you a gift card
for twenty-five dollars, you know, something”.
Providing incentives to clients was also considered a
facilitator, “Well, you know, our clients, some agencies
give our clients to come in, they give them gifts and food.
We don’t have incentives here. Clients have been incen-
tivized. And we provide no incentives, but they come in.
So sometimes an agency around the corner will be giving
out, just to give you an example, will be giving a fifty
dollar gift card to come in. They’ll go there, get the fifty
dollar gift card but then they eventually come back”
(Agency CEO).
Other distinct facilitators reflecting the capacity to adopt
included prior experience with adopting other innova-
tions, the existence of a quality improvement unit within
the agency, being in a supportive academic environment,
and having more information about the innovation itself.
Acceptability of adoption
The third theme focused on the acceptability of the EBPs
from the perspective of the staff responsible for using
them, the agency as a whole, and the clients or consumers
who are the presumed beneficiaries of the EBPs. Staff
resistance was the most frequently cited barrier, “When
you’re working with evidence-based practices that are dif-
ferent from what people are used to doing, you certainly
have to overcome staff resistance” (Agency vice president).
Lack of fit with the client and the client’s needs and
preferences is another barrier. The fit with client needs
is usually expressed in terms of a positive outcome. Lack
of a fit between the practice requirements and the
client’s preference is considered a barrier: “It’s also the
patient resistance to change and the lack of cooperation
from the parents” (Program director).
Finally, lack of fit of the innovation with the organisation
is another barrier, as one clinic manager noted, “And
obviously, yeah, anything that would go against the agency’s
mission, clearly, you know that we’re not going to touch”.
Facilitators related to acceptability of the innovation
included staff motivation to change current practices,
evidence of positive outcomes in addressing client need
and preferences, and the existence of a supportive lead-
ership and organisational culture. For instance, related
to evidence of positive outcomes was the manner in
which the information related to the innovation was
presented or ‘framed’. As explained by one program dir-
ector, “What motivates? Well, just how it’s presented to
me, how I present it to the staff meetings. Is it presented
to the managers the same way, basically saying this is
the new program, for instance, that we’re going to be
using and how this will be effective for clients? So I like
to see examples how it may help another program. Or I
like to see numbers and see how effective it is…. So once I
see those numbers, then I’m driving to make sure that it’s
in my program”.
The only facilitator related to acceptability that was not
the opposite of staff buy-in, organisational fit, and client
need and buy-in was the observation that other agencies
were also adopting the innovation. As expressed by one
agency CEO, “So if the health system’s doing it, then obvi-
ously it’s easy for us to do. If other hospitals are doing it
and we want to compete with other hospitals, or sometimes
we need to show that we’re doing it too”. A desire to remain
in good standing with OMH was also viewed as a facilitator
in that it created a pressure to adopt the innovation.
This pressure was cited by one program director:
“OMH, you know is pushing for person recovery…center
recovery, so that’s what we’re looking at. You know, we’re
trying to integrate that into our treatment approach”.
Weighing costs and benefits
Although participants were asked to identify barriers
and facilitators separately, it was evident in several in-
stances that both factored into some form of assessment
or calculation of the benefits relative to the costs. There
were several references to being motivated by EBPs as
being ‘cost effective’ and the need to determine whether
“the clinical value of the program or even the efficiency
value is an investment that we can afford to do, basic-
ally. We need to make that choice” (Agency CEO). Bene-
fits were viewed both in terms of improved outcomes
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for the individual client as well as improved productivity
or revenues for the agency as a whole. In some in-
stances, this assessment is made with the recognition
that the benefits are not immediate, but are likely to
occur at some point in the future. In other instances, the
benefits are not entirely clear, “Because some of the
trainings we pulled people out of their billing time. So we
make sacrifices. And I don’t know if it’s worth it, but we
do…” (Program director).
However, two particular patterns were observed in the
assessment of costs and benefits. The first pattern was a
focus almost entirely on the costs of adoption with an
expressed desire to avoid these costs with little or no
attention given to benefits. In many instances, the costs
are perceived to clearly outweigh the benefits. For in-
stance, one program director expressed an unwillingness
to adopt “…interventions that just don’t fit…that are not
user friendly, that are hard to fit into our practice, that
don’t seem to fit with the population that we’re serving.
Interventions that are very time consuming and require a
lot of other documentation or require a lot of additional
time. And then interventions that just don’t seem like
they’re effective. They just don’t make sense.”
In another instance, unless the innovative practice is
short-term, it may not be cost-effective because “the lon-
ger you’re working with a family the more questions and
challenges there are around the effectiveness of our work”
(Agency CEO).
The second pattern was the reliance on untested as-
sumptions in assessing costs and benefits. For instance,
references to staff resistance to change in general were
often based on personal experience and did not appear
to rely on ‘data’ based on the specific instance (i.e. a par-
ticular innovation), “You know, like certain…I know,
within myself and sense that maybe with colleagues,
there’s a certain resistance to change” (Program director).
Discussion
Our analyses of the perceived barriers and facilitators of
innovation adoption revealed an agency leadership
model of implementation based on assessments of the
cost and potential benefits of adoption, the organisation’s
capacity to adopt, and the acceptability of adoption to
the client, providers and the organisation itself. The cost
of adopting was the most frequently cited barrier,
followed by the organisation’s capacity to adopt and the
acceptability/fit of the innovation to clients, staff and the
organisation. In contrast, the available capacity for adop-
tion was the most frequently cited facilitator of adoption,
followed by acceptability and limited costs and potential
benefits.
In many respects, the agency leadership model priori-
tises the salient factors in existing models and frame-
works of adoption and implementation developed by
researchers [6–8]. For instance, if we take the Consoli-
dated Framework for Implementation Research [7] as an
illustration, all of the barriers and facilitators identified
by study participants reflect characteristics of innovation
(e.g. costs associated with implementing the program,
need for and availability of training and supervision evi-
dence of positive outcomes, flexibility, adaptability and
perceived excellence in how the program is presented),
the external environment or outer setting/context (avail-
ability of funds, client needs, regulatory mandates, pres-
sure from OMH and other agencies), the inner setting/
context (organisational structure, availability of trained
staff, fit with organisational culture, leadership support,
financial incentives for implementation), characteristics
of individuals (staff fit and buy-in), or implementation
process (presence of program champions). Costs, cap-
acity (fidelity) and acceptability also represent three of
eight implementation outcomes in the model proposed
by Proctor et al. [12]. Elements of the Consolidated
Framework for Implementation Research and other im-
plementation frameworks that are not especially salient
in the agency leadership model include the role of inter-
organisational networks, ability to test programs on a
small scale, client advocacy, planning, and evaluation or
fidelity monitoring.
The model also exhibits five of the six characteristics of
the innovation as described in Roger’s Diffusion of Innova-
tions Theory [22]. Relative advantage is represented in the
benefit of improved clinical outcomes. Compatibility is
represented in the barriers and facilitators related to organ-
isational fit and leadership support and staff buy-in and
motivation to change. Complexity is represented in EBP
requirements and flexibility. Observability is represented as
improved clinical outcomes and client acceptability. Trial-
ability was not represented in participant comments.
The agency leadership model of innovation adoption
revealed in this study also illustrates several principles of
behavioural economics [23–27]. In contrast to trad-
itional economic theory, which assumes that individuals
make rational decisions in order to maximise the utility
or personal benefits derived from their choices, behav-
ioural economics recognises the systematic biases inher-
ent in decision making and the notion of ‘bounded
rationality’ [27], and posits that utility is a subjective
concept representing the individual’s personal satisfac-
tion with the decision [24]. The principles of behavioural
economics were summarised by Rice [26] as follows, (1)
people tend to be overly oriented to the present rather
than the future (temporal discounting); they are more
concerned about losing something they have than about
gaining something they have not yet experienced (loss
aversion) and are very sensitive to monetary incentives,
especially those that are most tangible; (2) people are
cognitively limited, using heuristics or rules of thumbs
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to make complex decisions rather than going through all
possible choices, they exhibit decision fatigue, which
accounts for a preference for less rather than more
choice, and they are influenced by how choices are
framed (framing); and (3) people’s preferences are influ-
enced greatly by the environment and can be manipulated,
especially through advertising.
In this study, clinic leaders do appear to compare the
costs and benefits of adoption in accordance with princi-
ples of classical economic theory and models of com-
parative effectiveness research [28]. Benefits include
improved outcomes that address the needs of clients
and expanded service capacity. However, consistent with
the principle of loss aversion, the leaders also tend to
focus more on the costs than they do on the benefits of
innovation adoption. Costs were identified by the largest
percentage of study participants (85.2% versus 14.9%
who perceived positive outcomes as a benefit). They also
expressed concern over loss of staff that received add-
itional training, and reduced staff morale. Examples of
the use of heuristics included the untested assumption
that staff would resist adoption in general or that it
would require too much time to implement the innova-
tive practice. In these instances, there was no evidence
that leaders had polled their staff to determine how
receptive they would be to a particular innovation and
no evidence of a willingness to experiment (i.e. adopt
the innovation on a trial basis). Consistent with the
principle of temporal discounting, some agency adminis-
trators expressed concern over whether the long-term
benefits in clinic efficiency and client outcomes were
worth the short-term costs associated with lost product-
ivity during training. Consistent with the principle of
framing, agency administrators may be motivated to
adopt based on how the innovation is presented to them
and how they, in turn, present it to their staff. Consistent
with the principle of incentives, participants made refer-
ence to the incentive of having staff trained for free or at
low cost and incentivising use of the innovation by both
clients and practitioners as a potential facilitator to
adoption, one that none of the agencies studied appeared
to possess at present. Consistent with the principle of
decision fatigue and preference for limited choices, partic-
ipants expressed a preference for mandates as a facilitator
because it eliminated the need to make a decision. Reli-
ance on mandates and the pressure to adopt to remain in
good standing with the New York State Office of Mental
Health to motivate adoption is also consistent with the
principle of preferences being influenced by the environ-
ment that can be manipulated, along with other agencies’
adoption of innovation, as motivation to adopt.
However, for the individuals making the decision to
innovate, the determinants of successful implementation
can be reduced to answers to three simple questions, (1)
What will it cost me to innovate? (2) Do I have the cap-
acity to innovate? and (3) Am I motivated to innovate?
As the results indicate, the same information may be
used to answer more than one question. Thus, having a
supportive leadership reflects both a capacity for
innovation and a desire to do so from an organisational
perspective. Evidence of positive outcomes associated
with the innovation may be viewed as a benefit con-
trasted with the costs as well as a motivation by staff,
clients and organisations for adopting the innovation.
More importantly, the agency leadership model pre-
sented here suggests that the barriers and facilitators are
prioritised such that decision-makers give greater weight
to costs than to capacity or acceptability when evaluat-
ing barriers, but give greater weight to capacity than to
costs and acceptability when evaluating facilitators. The
most important costs from the perspective of agency
decision-makers are temporal and monetary. The lack of
trained staff is the most significant or salient barrier re-
lated to capacity. The reluctance of staff to adopt new
practices is the most significant or salient barrier related
to acceptability. Availability of time to innovate and evi-
dence of positive outcomes associated with the innovation
are the most important facilitators. Access to training ac-
tivities and materials and availability of financial support
and incentives are the most important capacity facilitators.
Organisational fit and leadership support are the most
important acceptance facilitators. Thus, while existing im-
plementation frameworks, theories and models may help
to guide implementation practice by identifying potential
barriers and facilitators that might be important to address
when undertaking an implementation endeavour, they are
more like checklists of factors relevant to various aspects
of implementation [11]. Decision-making models such as
the ones used by agency leaders in mental health clinics in
New York State are potentially useful in identifying the
most important factors within a specific context or
setting and devoting limited resources and strategies to
addressing these factors.
Finally, the data from this study seem to suggest key
factors that researchers should pay attention to and test in
quantitative models. In an earlier study with the entire
cohort of mental health clinics in New York State from
which this sample was drawn, Olin et al. [29] found clinic
size, efficiency and outsourcing were significantly associ-
ated with participation in business trainings and propor-
tion of youth clients and full-time clinical staff were
associated with participation in clinical trainings. The
present study enriches those findings by highlighting the
potential importance of local/contextual factors not avail-
able in state administrative data sets. This knowledge
should be used in combination with state administrative
data to help states develop targeted strategies for promoting
innovation adoption and implementation.
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This study has several limitations. As a qualitative
investigation, the generalisability of these findings is
limited to a sample of senior administrators of mental
health clinics serving children and adolescents in New
York State. The specific needs and perspectives of this
stakeholder group on barriers and facilitators to adopt
will likely differ from those of other stakeholders, includ-
ing state officials, therapists, non-clinical staff and cli-
ents. Surveys of a random sample of each stakeholder
group would increase the generalisability of these results.
Further, the reliance on answers provided to specific
questions during the interviews may limit the identifica-
tion and quantification of barriers and facilitators that
may be found in other parts of the interview. Although
findings were consistent with theories of behavioural
economics, the questions were not specifically designed
to examine adoption from that point of view and,
therefore, information about tradeoffs, etc., may have
been missed. Finally, the cross-sectional design of the
study also limits our ability to establish a causal link-
age between perceptions of barriers and facilitators
and degree of engagement in innovation adoption and
implementation. Related to this, the findings of this
study relate primarily to the early or initial stages of
implementation and may not include perceptions of
barriers and facilitators associated with sustainment of
such innovations.
Conclusion
Despite these limitations, our findings illustrate an agency
leadership model of innovation adoption reflecting certain
principles of behavioural economics. There appears to be
a high level of consensus as to perceived costs and bene-
fits, capacity to adopt and acceptability of the innovation.
Furthermore, the findings point to areas where current
models can be enhanced or modified, particularly with
respect to the prioritisation of barriers and facilitators, as
well as to the need to take local stakeholders into
consideration when developing strategies to facilitate
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